{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:33:58Z","timestamp":1759937638230,"version":"3.44.0"},"reference-count":17,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2018,12,16]]},"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:p>After 25 years of continuous lithium therapy, a woman with moderate intellectual disability and bipolar disorder developed symptoms suggestive of dementia. In fact, she had developed lithium neurotoxicity, but this was overlooked for 18 months as serial lithium levels were in the therapeutic range.<\/jats:p>","DOI":"10.1136\/bcr-2018-227741","type":"journal-article","created":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T04:18:49Z","timestamp":1547785129000},"page":"bcr-2018-227741","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":10,"title":["Lithium neurotoxicity presenting as dementia with therapeutic serum lithium levels"],"prefix":"10.1136","volume":"12","author":[{"given":"Sarita","family":"Soni","sequence":"first","affiliation":[{"name":"Department of Learning Disabilities, NHS Greater Glasgow and Clyde, Glasgow, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2019,1,17]]},"reference":[{"key":"2025082706485858000_12.1.bcr-2018-227741.1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.6116.815"},{"key":"2025082706485858000_12.1.bcr-2018-227741.2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.52.5.679"},{"key":"2025082706485858000_12.1.bcr-2018-227741.3","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.162.5.689"},{"key":"2025082706485858000_12.1.bcr-2018-227741.4","doi-asserted-by":"publisher","DOI":"10.3109\/00048679609065059"},{"key":"2025082706485858000_12.1.bcr-2018-227741.5","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/01.pra.0000344921.36157.dc","article-title":"Neurotoxicity with therapeutic lithium levels: a case report","volume":"15","author":"Grueneberger","year":"2009","journal-title":"J Psychiatr Pract"},{"key":"2025082706485858000_12.1.bcr-2018-227741.6","doi-asserted-by":"crossref","DOI":"10.1176\/jnp.2010.22.4.451.e29","article-title":"Lithium neurotoxicity at normal serum levels","volume":"22","author":"Mesquita","year":"2010","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"2025082706485858000_12.1.bcr-2018-227741.7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/JCP.0000000000000181","article-title":"Severe neurotoxicity associated with low-level serum lithium and risperidone after 25 years of uncomplicated lithium therapy","volume":"34","author":"Goyal","year":"2014","journal-title":"J Clin Psychopharmacol"},{"key":"2025082706485858000_12.1.bcr-2018-227741.8","first-page":"103","article-title":"Case report on lithium intoxication with normal lithium levels","volume":"26","author":"Peng","year":"2014","journal-title":"Shanghai Arch Psychiatry"},{"key":"2025082706485858000_12.1.bcr-2018-227741.9","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/01.pra.0000462608.02478.16","article-title":"A case with reversible neurotoxicity after 2 years of dementia secondary to maintenance lithium treatment","volume":"21","author":"Soriano-Barcel\u00f3","year":"2015","journal-title":"J Psychiatr Pract"},{"key":"2025082706485858000_12.1.bcr-2018-227741.10","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2788.2007.00965.x","article-title":"The effectiveness of mood stabilizers and antiepileptic medication for the management of behaviour problems in adults with intellectual disability: a systematic review","volume":"52","author":"Deb","year":"2008","journal-title":"J Intellect Disabil Res"},{"key":"2025082706485858000_12.1.bcr-2018-227741.11","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-013-0039-0"},{"key":"2025082706485858000_12.1.bcr-2018-227741.12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198911303212201"},{"key":"2025082706485858000_12.1.bcr-2018-227741.13","doi-asserted-by":"crossref","unstructured":"Netto I , Phutane VH . Reversible lithium neurotoxicity: review of the literatur. Prim Care Companion CNS Disord 2012;14.doi:10.4088\/PCC.11r01197","DOI":"10.4088\/PCC.11r01197"},{"key":"2025082706485858000_12.1.bcr-2018-227741.14","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcm017"},{"key":"2025082706485858000_12.1.bcr-2018-227741.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2012.05.060"},{"key":"2025082706485858000_12.1.bcr-2018-227741.16","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/WNF.0b013e31814a619d","article-title":"Delirium associated with lithium-quetiapine combination","volume":"31","author":"Miodownik","year":"2008","journal-title":"Clin Neuropharmacol"},{"key":"2025082706485858000_12.1.bcr-2018-227741.17","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1614.2001.00963.x"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2018-227741","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T13:49:11Z","timestamp":1756302551000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2018-227741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1,17]]},"published-print":{"date-parts":[[2019,1]]}},"alternative-id":["10.1136\/bcr-2018-227741"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2018-227741","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2019,1]]}}}